Jane L Yang ¹, Emmanuelle Hodara ¹, Intira Sriprasert, Donna Shoupe, Frank Z Stanczyk ²

Affiliations Expand

• PMID: 39081162
• PMCID: PMC12072814
• DOI: 10.1097/GME.0000000000002407

Abstract

Menopause, defined by the cessation of menstrual cycles after 12 months of amenorrhea not due to other causes, is associated with significant hormonal changes, primarily a decrease in estrogen, androgen, and progesterone levels. This review delves into the effects of estrogen deficiency during the perimenopausal transition and postmenopause, integrating the findings of basic science with clinical trials. Here, we first outline the variation in endogenous estrogens before and after menopause, exploring both genomic and nongenomic actions of estrogen and its estrogen receptors throughout the body. Next, we detail the spectrum of menopausal symptoms, from acute vasomotor, urogenital, and psychological issues during perimenopause to chronic reproductive, cardiovascular, neurological, skeletal, dermatologic, immune, and digestive changes postmenopause. Finally, we evaluate the role of hormone therapy in alleviating these symptoms, weighing its benefits against known risks. Publicizing these findings and an accurate representation of the risks and benefits of estrogen replacement to our aging patients is fundamental to improving their care, quality, and even quantity of life.

Copyright © 2024 by The Menopause Society.

PubMed Disclaimer

Conflict of interest statement

Financial disclosure/Conflicts of interest: None reported.

Figures

Similar articles

• Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement.Viscomi B, Muniz M, Sattler S.J Cosmet Dermatol. 2025 Sep;24 Suppl 4(Suppl 4):e70393. doi: 10.1111/jocd.70393.PMID: 40847905Free PMC article.Review.
• Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.Genazzani AR, Monteleone P, Giannini A, Simoncini T.Hum Reprod Update. 2021 Oct 18;27(6):1115-1150. doi: 10.1093/humupd/dmab026.PMID: 34432008Clinical Trial.
• The menopause: benefits and risks of estrogen-progestogen replacement therapy.Gambrell RD Jr.Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2.PMID: 7040116Review.
• [Menopause and hormone replacement therapy].Tóth KS.Orv Hetil. 2000 Mar 12;141(11):547-56.PMID: 10741167Review.Hungarian.
• Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.Brinton RD.Ann N Y Acad Sci. 2005 Jun;1052:57-74. doi: 10.1196/annals.1347.005.PMID: 16024751

See all similar articles

Cited by

• Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement.Viscomi B, Muniz M, Sattler S.J Cosmet Dermatol. 2025 Sep;24 Suppl 4(Suppl 4):e70393. doi: 10.1111/jocd.70393.PMID: 40847905Free PMC article.Review.
• Assessing the Roles of Aging, Estrogen, Nutrition, and Neuroinflammation in Women and Their Involvement in Alzheimer’s Disease-A Narrative Overview.Lephart ED, Weber KS, Hedges DW.Int J Mol Sci. 2026 Jan 26;27(3):1239. doi: 10.3390/ijms27031239.PMID: 41683663Free PMC article.Review.
• Exploring Genital Lichen Sclerosus: Navigating from Pathophysiology to Precise Diagnostic Approaches.Sever M, Trčko K, Zidarič T, Maver T.Biomedicines. 2025 Sep 12;13(9):2252. doi: 10.3390/biomedicines13092252.PMID: 41007812Free PMC article.Review.
• Round Table Discussion: Aesthetic Treatment Considerations for the Perimenopausal & Menopausal Patient.Fabi SG, Firsowicz M, Kamrani P, Draelos ZD, Dayan SH.J Cosmet Dermatol. 2026 Jan;25(1):e70626. doi: 10.1111/jocd.70626.PMID: 41461019Free PMC article.Review.
• Differential symptom relief profiles of menopausal therapies: an online survey study.Martin-Key NA, Funnell EL, Tomasik J, Bahn S.BMC Womens Health. 2025 Aug 4;25(1):384. doi: 10.1186/s12905-025-03929-3.PMID: 40760434Free PMC article.

See all “Cited by” articles

References

1. 1. Nelson HD. Menopause. Lancet 2008;371:760–770. doi: 10.1016/S0140-6736(08)60346-3 – DOI – PubMed
   1. Wright JV, Schliesman B, Robinson L. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Altern Med Rev 1999;4:266–270. – PubMed
   1. Hetemäki N, Mikkola TS, Tikkanen MJ, et al. Adipose tissue estrogen production and metabolism in premenopausal women. J Steroid Biochem Mol Biol 2021;209:105849. doi: 10.1016/j.jsbmb.2021.105849 – DOI – PubMed
   1. Sundermann EE, Maki PM, Bishop JR. A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition. Menopause 2010;17:874–886. doi: 10.1097/gme.0b013e3181df4a19 – DOI – PMC – PubMed
   1. Kumar R, Zakharov MN, Khan SH, et al. The dynamic structure of the estrogen receptor. J Amino Acids 2011;2011:812540. doi: 10.4061/2011/812540 – DOI – PMC – PubMed

Show all 139 references

Publication types

• Review

MeSH terms

• Clinical Trials as Topic
• Estrogen Replacement Therapy*
• Estrogens* / deficiency
• Female
• Humans
• Menopause* / physiology

Substances

• Estrogens

Related information

• GEO Profiles
• MedGen

Grants and funding

• F30 CA257401/CA/NCI NIH HHS/United States

LinkOut – more resources

MedlinePlus Health Information

Full Text Sources

Ovid Technologies, Inc.

PubMed Central

Wolters Kluwer

Medical